Showing 861 - 880 results of 15,077 for search '"standardization"', query time: 0.10s Refine Results
  1. 861
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868
  9. 869

    ŠKOLE SENJSKOG PODGORJA by MIRKO RAGUŽ

    Published 2017-01-01
    Subjects:
    Get full text
    Article
  10. 870
  11. 871
  12. 872

    THE EFFECT OF PACKAGING TYPE AND STORAGE TEMPERATURE ON THE SHORT TERM STABILITY OF ELECTROLYTIC CONDUCTIVITY REFERENCE MATERIALS by AYU HINDAYANI, OMAN ZUAS, NURYATINI HAMIM

    Published 2021-06-01
    Subjects: “…chemical metrology, calibration, homogeneity, primary standard solution, traceability.…”
    Get full text
    Article
  13. 873
  14. 874
  15. 875
  16. 876
  17. 877
  18. 878
  19. 879

    Cataloguing and Classification : an introduction to aacr2, rca, ddc, lcc, lcsh and marc 21 standards / by Lazarinis, Fortis

    Published 2014
    “…an introduction to aacr2, rca, ddc, lcc, lcsh and marc 21 standards /…”
    View in OPAC
    Book
  20. 880

    Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context by Gabriela Tapia-Calle, Gloria Aguilar, Nathalie Vaissiere, Carla Truyers, Pedro Ylisastigui, Erik Buntinx, Mathieu Le Gars, Frank Struyf, Gert Scheper, Macaya Douoguih, Javier Ruiz-Guiñazú, Robert Patrizi, Wai Ling, Sanne de Ridder, Marit de Groot, Maria Grazia Pau, Gerald Weidinger, Srividya Pradeep, Nadine Salisch, Sophie Cambre

    Published 2025-01-01
    “…Participants aged ≥18–64 years were randomised to receive a seasonal quadrivalent standard dose (SD) influenza vaccine (Afluria Quadrivalent, Seqirus) concomitantly with Ad26.COV2.S (Coad_SD) or placebo (0.9% NaCl; Control_SD) on Day 1 and placebo or Ad26.COV2.S on Day 29. …”
    Get full text
    Article